Anti-thrombotic strategies in patients with atrial fibrillation undergoing PCI.

Clinical Research in Cardiology : Official Journal of the German Cardiac Society
A SchäferJohann Bauersachs

Abstract

Triple anti-thrombotic therapy combining oral anticoagulation and dual anti-platelet therapy following percutaneous coronary intervention in patients with atrial fibrillation was considered as standard and recommended by guidelines. While bleeding risk is considerable with that approach, data for efficacy are scare. Several trials assessed the possibility of reducing anti-thrombotic treatment by mainly shortening the exposure to acetylsalicylic acid. Dropping one of the anti-platelet components might increase the risk of stent thrombosis, myocardial infarction or stroke. Despite that fear, the recent trials' primary endpoint was major and/or clinically-relevant non-major bleeding. We review data on major bleedings, intracranial bleedings and major adverse cardiovascular events from the published reports. We demonstrate that Non-Vitamin K oral anticoagulant (NOAC)-based strategies compared to VKA-based triple therapies significantly reduce the risk for TIMI-major bleedings by 39% and for intracranial bleedings by 66%, while they did not increase the risk for overall ischemic or embolic events. However, recent meta-analyses indicate an increased risk for stent thrombosis with less intense anti-thrombotic therapy. While the overal...Continue Reading

References

Sep 2, 1993·The New England Journal of Medicine·UNKNOWN GUSTO investigators
Sep 12, 2003·The New England Journal of Medicine·Elaine M HylekDaniel E Singer
Apr 22, 2005·Journal of Thrombosis and Haemostasis : JTH·S SchulmanUNKNOWN Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on T
Sep 1, 2009·The New England Journal of Medicine·Stuart J ConnollyUNKNOWN RE-LY Steering Committee and Investigators
Sep 1, 2009·The New England Journal of Medicine·Lars WallentinMona Thorsén
Sep 2, 2009·Annals of Internal Medicine·Daniel E SingerAlan S Go
Feb 12, 2011·The New England Journal of Medicine·Stuart J ConnollyUNKNOWN AVERROES Steering Committee and Investigators
Jul 26, 2011·The New England Journal of Medicine·John H AlexanderUNKNOWN APPRAISE-2 Investigators
Aug 30, 2011·The New England Journal of Medicine·Christopher B GrangerUNKNOWN ARISTOTLE Committees and Investigators
Nov 15, 2011·The New England Journal of Medicine·Jessica L MegaUNKNOWN ATLAS ACS 2–TIMI 51 Investigators
Mar 27, 2012·The New England Journal of Medicine·David A MorrowUNKNOWN TRA 2P–TIMI 50 Steering Committee and Investigators
Feb 28, 2015·Journal of the American College of Cardiology·Marco ValgimigliUNKNOWN ZEUS Investigators
May 16, 2015·European Heart Journal·Riccardo CappatoUNKNOWN VENTURE-AF Investigators
Aug 12, 2016·Zeitschrift für Gastroenterologie·W FischbachUNKNOWN Verantwortlich für die DGVS
Aug 28, 2016·European Heart Journal·Paulus KirchhofUNKNOWN ESC Scientific Document Group
Dec 3, 2016·Science Translational Medicine·Tobias PetzoldSteffen Massberg
Dec 14, 2016·The New England Journal of Medicine·C Michael GibsonKeith A Fox
Aug 29, 2017·The New England Journal of Medicine·Christopher P CannonUNKNOWN RE-DUAL PCI Steering Committee and Investigators
Mar 27, 2018·European Heart Journal·Paulus KirchhofLuigi Di Biase
Apr 13, 2018·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Nicolas A GeisRaffi Bekeredjian
Apr 29, 2018·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Karl Georg HaeuslerRenate Schnabel
Aug 31, 2018·European Heart Journal·Franz-Josef NeumannUNKNOWN ESC Scientific Document Group
Jan 4, 2019·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Lisa EggebrechtPhilipp Sebastian Wild

❮ Previous
Next ❯

Citations

Aug 28, 2021·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Andreas SchäferJohann Bauersachs

❮ Previous
Next ❯

Software Mentioned

RE
PIONEER
AUGUSTUS
SPAF
WOEST
DEEM

Related Concepts

Related Feeds

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Related Papers

Current Treatment Options in Cardiovascular Medicine
Bharath Rajagopalan, Christopher Madias
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology
Philipp HalbfassEllen Hoffmann
© 2021 Meta ULC. All rights reserved